Ditto Biosciences

Seed / Series A

defense-other · Seed

Seed Signal Score

9/25

Team Strength

2/5

Validation Depth

2/5

Novelty

2/5

Market Timing

1/5

Capital Efficiency

2/5

www.dittobio.com/

Description

Evolutionary intelligence for autoimmune disease

Validation Signals

yc batch

Score Rationale

Ditto Biosciences appears to be a biotech company focused on autoimmune disease with no visible defense application, defense-domain expertise, or connection to DoD priorities. YC acceptance provides some credibility (validation_depth: 2), but the company lacks named founders, government contracts, defense customers, or clear positioning within the defense-tech landscape that would justify investment by a defense-focused fund.

Back to all companies